Cerebra AI

Palo Alto · founded 2018
HealthTech & MedTech Seed Open sources

AI platform for ultra-early stroke diagnosis from CT scans. US agreement expanding into cardiology and oncology, with an FDA regulatory submission planned for 2027.

About

Cerebra AI is an artificial intelligence system for ultra-early automated diagnosis of ischemic stroke using computed tomography (CT) scans. The project originated in 2018 in Almaty (Almaty AI Lab) under founder Doszhan Zhussupov, and in 2024 the company relocated its global headquarters to Palo Alto (USA, 320 High Street). On October 12, 2023, the startup raised a $4.1 million Seed 2 round led by Big Sky Capital with participation from Most Ventures, Aloqa Ventures, Uzcard Ventures, Timur Turlov, UMAY Angels, and Ynta Group (Quest Ventures had previously invested in the company).

In September 2026, Cerebra AI signed a five-year strategic agreement with a leading US medical group to expand its diagnostic platform into cardiovascular and oncological diseases. The company also announced the need for an additional clinical study and plans for a US regulatory submission in 2027.

Founders

DZ
Doszhan ZhussupovCEO

Team information is compiled from open sources and may be updated by our editors.

RAEM Coverage

Profile history

Profile published in directory
Editorial data verification

Sources

Is this your company?

Verify that you represent Cerebra AI to update this profile and receive inquiries from investors and partners.

Similar startups

All in sector →
$4.1M · SeedHealthTech · Palo AltoWebsite ↗
REPRESENTATIVE VERIFICATION

Claim company representative access

Verified representatives can update metrics, publish company news to the feed, and receive direct investor inquiries.

✓

Request sent